Accelerate Your Research: Dispen3D Harnesses the Power of 3D Models

FHS
July 12, 2024
1:33 pm

Dispen3D is setting new standards in single-cell biology, enabling researchers to conduct high-precision experiments that drive advancements in drug discovery, personalized medicine, and regenerative therapies.

AstraZeneca concludes equity investment in Cellectis

AstraZeneca maintains an option for a global exclusive licence for the candidate products developed through the deal. Credit: Robert Way / Shutterstock.com. AstraZeneca has concluded

May 7, 2024

Federal government shutdown watch: FDA and industry prep for likely closure Oct. 1

The federal government is bracing for a shutdown if lawmakers on Capitol Hill can’t rally enough votes to keep the government funded by the end

September 29, 2023

Brain Implant Helps ALS Patient Quickly Restore Conversational Communication

A novel brain implant helped an ALS patient with severe dysarthria communicate quickly. Another ALS patient was able use her brain-computer interface for about 7

August 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.